GRANULOMAS IN PRIMARY SCLEROSING CHOLANGITIS

被引:0
作者
LUDWIG, J [1 ]
COLINA, F [1 ]
POTERUCHA, JJ [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV GASTROENTEROL & INTERNAL MED,ROCHESTER,MN 55905
来源
LIVER | 1995年 / 15卷 / 06期
关键词
GRANULOMAS; LIVER; PRIMARY SCLEROSING CHOLANGITIS;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Granulomas in liver biopsy specimens from adult patients with chronic ductopenic cholestatic liver disease are a characteristic feature of primary biliary cirrhosis. However, we found a similar combination of abnormalities in 7 out of 100 native livers (7%) from patients who had orthotopic liver transplantation for primary sclerosing cholangitis. In a control group of native livers from 100 patients with primary biliary cirrhosis, the prevalence of granulomas was exactly the same, 7%. In the primary sclerosing cholangitis group, 13 additional livers showed a granulomatous epithelioid cell response, with or without foreign body type giant cells, to extravasated bile. Ail granulomas were noncaseating and non-necrotizing; they consisted of epithelioid cells and often contained giant cells. Perigranulomatous lymphocytic infiltrates were generally mild to moderate. The granulomas involved portal tracts, scars, and hepatic parenchyma. Biopsy experience revealed that granulomas can be found in all stages of the disease. In contradistinction to the granulomas in primary biliary cirrhosis, the granulomas in primary sclerosing cholangitis did not represent granulomatous cholangitis - that is, they were not a feature of the duct destruction. The etiology of these lesions is not dear, but in some cases we found strong morphologic evidence that granulomas may form as a response to the leakage of bile or bile components. No evidence of infection or of sarcoidosis was found. Although adverse drug responses cannot be ruled out with certainty, review of the clinical histories made that mechanism unlikely. Thus, the presence of granulomas in chronic ductopenic cholestatic liver disease is not pathognomonic for primary biliary cirrhosis and, in rare instances (on average, in 3-4% of the biopsy samples), may be a feature of primary sclerosing cholangitis.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 50 条
  • [21] The Microbiome and Primary Sclerosing Cholangitis
    Ali, Ahmad H.
    Carey, Elizabeth J.
    Lindor, Keith D.
    SEMINARS IN LIVER DISEASE, 2016, 36 (04) : 340 - 348
  • [22] Autoantibodies in primary sclerosing cholangitis
    Hov, Johannes Roksund
    Boberg, Kirsten Muri
    Karlsen, Tom H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (24) : 3781 - 3791
  • [23] Update on primary sclerosing cholangitis
    Karlsen, Tom H.
    Boberg, Kirsten Muri
    JOURNAL OF HEPATOLOGY, 2013, 59 (03) : 571 - 582
  • [24] Update on primary sclerosing cholangitis
    Karlsen, Tom H.
    Schrumpf, Erik
    Boberg, Kirsten M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (06) : 390 - 400
  • [25] Primary sclerosing cholangitis and malignancy
    Boberg, Kirsten Muri
    Lind, Guro E.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (06) : 753 - 764
  • [26] Management of primary sclerosing cholangitis
    Lutz, Holger H.
    Tischendorf, Jens J. W.
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (06) : 137 - 141
  • [27] Management of primary sclerosing cholangitis
    Holger H Lutz
    Jens JW Tischendorf
    World Journal of Hepatology, 2011, (06) : 137 - 141
  • [28] Autoantibodies in primary sclerosing cholangitis
    Johannes Roksund Hov
    Kirsten Muri Boberg
    Tom H Karlsen
    World Journal of Gastroenterology, 2008, (24) : 3781 - 3791
  • [29] Epidemiology of primary sclerosing cholangitis
    Schrumpf, E
    Boberg, KM
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (04) : 553 - 562
  • [30] Immunogenetics in primary sclerosing cholangitis
    Chung, Brian K.
    Hirschfield, Gideon M.
    CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (02) : 93 - 98